Clinical Trial Update: PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology [NA]

View source ↗

Summary

PRO-VISION is a clinical trial evaluating patient-reported outcomes for side effects of VEGF inhibitors in renal cell carcinoma; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Renal Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING